Diabetes & metabolism
Clinical research into diabetes, insulin therapy and metabolic disorders, with the aim of advancing evidence-based treatment.
PHYSICIAN. SCIENTIST. ORIGINATOR.
Prof. Thomas Pieber connects clinical experience with scientific research – and medical questions with new diagnostic possibilities.
Internal medicine · Endocrinology · Diabetology

Physician & scientist01 / PERSONAL PROFILE
Good medicine needs experience. Progress needs the willingness to ask new questions.
Thomas Pieber is a specialist in internal medicine and heads the Division of Endocrinology and Diabetology at the Medical University of Graz. His career spans patient care, clinical research and the development of new medical technologies.
A central question guides this work: how can scientific knowledge translate into a tangible benefit for people?
More about Thomas Pieber02 / MEDICINE & RESEARCH
Clinical research into diabetes, insulin therapy and metabolic disorders, with the aim of advancing evidence-based treatment.
Glucose sensing and technological approaches to diabetes care connect medical questions with precise measurement.
Translating a medical research question into a practical diagnostic solution is also at the heart of the involvement in Elyte Diagnostics.
03 / RESEARCH MEETS INNOVATION
Measuring potassium at home: Elyte Diagnostics is developing a diagnostic approach for people at risk of potassium imbalances.
Thomas Pieber originated the research idea and is involved in Elyte Diagnostics as an investor.
04 / SCIENTIFIC WORK
Pieber TR et al. · A clinical investigation of the pharmacology of once-weekly basal insulin in type 2 diabetes. The study examines concentration profiles and glucose-lowering effects, not long-term clinical outcomes.
von Herrath M et al., including Thomas R. Pieber · A randomised phase 2 trial investigating preservation of beta-cell function in recent-onset type 1 diabetes. An example of disease-modifying research, not an established cure.
CBMED / RESEARCH INTO PRACTICE
CEO at CBmed, together with Robert Lobnig
CBmed connects clinical and biomedical research with patient-focused application. As CEO, Thomas Pieber contributes his experience in an environment where academic institutions, healthcare providers and industry partners work together.
Translational biomarker research and precision medicine are central themes at CBmed. Biomarkers are measurable biological characteristics that can, for example, help characterise diseases or investigate treatments.
Discover CBmedOfficial CBmed update on the leadership role
CBmed and Elyte Diagnostics are presented as separate engagements; no partnership between the two is implied.
ROOTED IN GRAZ. INTERNATIONALLY MINDED.
At the Medical University of Graz, clinical care, research and teaching come together. This environment is the foundation of Thomas Pieber’s scientific work.
Academic work
PROGRESS STARTS WITH A CONVERSATION.
Interested in Elyte Diagnostics as an investor, or in discussing the scientific work? Thomas Pieber welcomes a personal conversation.
Request an investor conversation thomas.pieber@medunigraz.atMore ways to get in touch